Today: 30 April 2026
Browse Category

NZX:SKC 13 November 2025

New Zealand Sharemarket Today: NZX 50 Slides 0.5% as Infratil Sell‑Off Caps Mainfreight Rally (13 November 2025)

New Zealand Sharemarket Today: NZX 50 Slides 0.5% as Infratil Sell‑Off Caps Mainfreight Rally (13 November 2025)

New Zealand’s S&P/NZX 50 Index fell 0.54% to 13,597.87 on Thursday, retreating from recent highs above 13,700. Infratil dropped 5.5% despite reporting higher earnings and asset sales, while Mainfreight surged nearly 9% and SkyCity rose over 6% on heavy trading. Market breadth was negative, with 30 stocks down and 16 up. October electronic card spending rose just 0.2% from the previous month.
13 November 2025

Stock Market Today

  • Semiconductor Stocks Gain on Big Tech AI Spending, Qualcomm Beats Estimates
    April 30, 2026, 9:08 AM EDT. Semiconductor stocks climbed Thursday following strong earnings from Big Tech firms Meta and Microsoft, signalling increased capital expenditure on artificial intelligence (AI) infrastructure. Qualcomm surged 9% premarket after better-than-expected Q1 results and optimism about the Chinese phone market bottoming out. Intel, AMD, and Broadcom also rose, benefiting from demand for AI-focused central processing units (CPUs). Memory and storage companies Sandisk, Western Digital, and Seagate advanced after Seagate's solid results. Qualcomm additionally anticipates shipping custom silicon to an unnamed hyperscaler later this year. Investor interest in agentic AI, where bots act autonomously for users, continues to bolster the chip sector. Analyst Ming-Chi Kuo highlighted Qualcomm's collaboration with OpenAI on smartphone processors, contributing to the recent 15% surge in Qualcomm shares.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop